4//SEC Filing
Stirrup Allison 4
Accession 0002030386-25-000004
CIK 0002011641other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 1:19 PM ET
Size
21.8 KB
Accession
0002030386-25-000004
Insider Transaction Report
Form 4
Stirrup Allison
Chief Human Resources Officer
Transactions
- Tax Payment
Common Stock
2025-10-13$231.47/sh−740$171,288→ 6,027 total - Award
Common Stock
2025-10-14+76→ 137 total(indirect: By Spouse) - Exercise/Conversion
Conditional Share Award
2025-10-13−493→ 0 total→ Common Stock (493 underlying) - Award
Stock Options (Right to Buy)
2025-10-14+1,496→ 1,496 totalExercise: $235.00Exp: 2035-10-14→ Common Stock (1,496 underlying) - Award
Common Stock
2025-10-13+1,144→ 6,204 total - Gift
Common Stock
2025-10-13−70→ 4,988 total - Exercise/Conversion
Common Stock
2025-10-13+563→ 6,767 total - Award
Common Stock
2025-10-14+731→ 5,719 total - Sale
Common Stock
2025-10-13$234.23/sh−969$226,969→ 5,058 total - Exercise/Conversion
Conditional Share Award
2025-10-13−70→ 0 total(indirect: By Spouse)→ Common Stock (70 underlying)
Footnotes (9)
- [F1]The Common Stock was received in settlement of an October 13, 2022 grant under the Ferguson Enterprises Inc. Performance Ordinary Share Plan 2019, pursuant to certification of performance on September 10, 2025 by the Compensation Committee. Includes 142 shares acquired by Spouse that are held in joint brokerage account.
- [F2]Includes 86 shares previously held in Indirect Holdings by Spouse that were transferred to a joint brokerage account now owned directly.
- [F3]The Common Stock was received in settlement of a Conditional Share Award that vested on October 13, 2025. Includes 70 shares acquired by Spouse that are held in joint brokerage account.
- [F4]Includes 65 shares from Spouse.
- [F5]The reported price represents the volume-weighted average price (VWAP) of shares sold on the New York Stock Exchange . Sale prices for the reported transaction reported ranged between $234.200 and $234.275. Full information regarding the number of shares of Common Stock sold at each separate price in the range will be provided to the SEC, the Issuer or its shareholders upon request.
- [F6]The reported transaction represents a bona-fide charitable gift to a Donor Advised Fund.
- [F7]The reported securities represent Restricted Stock Units granted under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan, which entitles the Reporting Person to receive the stated amount of Common Stock in three equal annual installments beginning on October 14, 2026 (the Vesting Dates), subject to the Reporting Person's continued service through the Vesting Dates or retirement, if eligible.
- [F8]The Common Stock was received in settlement of a Conditional Share Award that vested on October 13, 2025.
- [F9]The reported securities represent Stock Options granted under the Ferguson Enterprises Inc. 2023 Omnibus Equity Incentive Plan, which entitles the Reporting Person to receive the stated amount of Stock Options in three equal annual installments beginning on October 14, 2026, (the "Vesting Dates"), subject to the Reporting Person's continued service through the Vesting Dates or retirement, if eligible.
Documents
Issuer
Ferguson Enterprises Inc. /DE/
CIK 0002011641
Entity typeother
Related Parties
1- filerCIK 0002030386
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 1:19 PM ET
- Size
- 21.8 KB